Search

Displaying results 8401 - 8410 of 10000 in total
  1. Drug

    Fasudil

    go.drugbank.com/drugs/DB08162
    Investigational

    Fasudil has been investigated in Carotid Stenosis.

  2. Drug

    Cannabivarin

    go.drugbank.com/drugs/DB14736
    Experimental

    A natural product found in Cannabis sativa.

  3. Drug

    R3R01

    go.drugbank.com/drugs/DB18078
    Investigational

    R3R01 is an investigational lipid-modifying drug.

  4. Drug

    Garlic oil

    go.drugbank.com/drugs/DB15989
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Dihydroxyacetone

    go.drugbank.com/drugs/DB01775
    Experimental

    It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. [PubChem] … A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage.

  6. Drug

    SB 11285

    go.drugbank.com/drugs/DB17511
    Investigational

    SB 11285 is a second-generation Stimulator of Interferon Genes (STING) agonist. … [L45123] SB 11285 is under investigation in clinical trial NCT04096638 (Evaluating Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors).

  7. Drug

    FF-10501-01

    go.drugbank.com/drugs/DB17554
    Investigational

    [A257306] FF-10501-01 is under investigation in clinical trial NCT03486353 (A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome). … FF-10501-01 is a novel, selective inosine monophosphate dehydrogenase (IMPDH) inhibitor with anticancer activity.

  8. Drug

    Tadekinig alfa

    go.drugbank.com/drugs/DB14858
    Investigational

    Tadekinig alfa is under investigation in clinical trial NCT03113760 (Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency).

  9. Drug

    Iomazenil

    go.drugbank.com/drugs/DB14971
    Investigational

    Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).

  10. Drug

    TSHA-105

    go.drugbank.com/drugs/DB18328
    Investigational

    TSHA-105 is an adeno-associated virus serotype 9 (AAV9) vector with an engineered transgene encoding the human SLC13A5 protein.